Indian drugmaker Cipla has appointed Umang Vohra as its new managing director and global chief executive to replace the outgoing Subhanu Saxena. 16 August 2016
The chairman of the management board of German drugmaker Stada Arzneimittel has resigned due to personal circumstances, the company has announced. 16 August 2016
Ireland-incorporated Perrigo has announced that Douglas Boothe, the general manager of its Rx Pharmaceuticals segment, is leaving the company. 21 July 2016
Valeant Pharmaceuticals (NYSE: VRX) has announced the return of J. Michael Pearson as chief executive following his recovery from severe pneumonia. 29 February 2016
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.